Organoids are made to model human organs and are promising for research and therapy, but there are limitations to their growth and function. A recent study by researchers at The University of Tokyo ...

The Siegert group at the Institute of Science and Technology Austria (ISTA) presents a new organoid model that reveals details of the developing nervous system's response to viral infections ...

By promoting liver progenitor cell expansion through a specific signaling pathway, this method offers a promising route to improve organoid models and regenerative medicine. Organoids are made to ...

As a pioneer of ovarian tissue cryopreservation and transplantation in China, Ruan is not only dedicated to advancing the technology but also hopes to ensure that patients are fully informed about ...

Hideki Taniguchi from The Institute of Medical Science, The University of Tokyo, Japan, has now made an important discovery in the field of organoid development. Published online in Nature ...

Mont-Saint-Guibert, Belgium, April 10, 2025 - Cellistic, a pioneer in induced pluripotent stem cells (iPSC)-based cell therapies ... encompassing filling, labelling and cryopreservation using ...

A number of other equities analysts have also issued reports on IPSC. Guggenheim decreased their target price on shares of Century Therapeutics from $12.00 to $5.00 and set a “buy” rating for ...

The partners aim to industrialize what they claim will be the first clinical-stage autologous induced pluripotent stem cell-derived (iPSC) therapy for peripheral artery disease and coronary artery ...

These next-generation formulations are expected to launch within 18 months and have the potential to provide superior cryopreservation outcomes for certain biological constructs, utilize lower ...